April 8, 2021

Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): clinical characteristics

• Anti-hypertensive medications, including angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and calcium channel blockers (CCB), were not associated with mortality among hospitalized COVID-19 patients in a retrospective cohort study (n=841). However, use of ACEI/ARB and ACEI/ARB combined with CCB were associated with a 42% and 45% lower risk of ICU admission, respectively. Among patients with a history of hypertension (n=453), ACEI use was associated with a 71% lower risk of in-house mortality.

Choksi et al. (Apr 7, 2021). Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers. American Journal of Nephrology. https://doi.org/10.1159/000515232